The FDA assessed the safety and usefulness of atidarsagene autotemcel depending on facts from 37 small children who been given atidarsagene autotemcel in two one-arm, open-label medical trials and in an expanded access program.[seven] Small children who been given procedure with atidarsagene autotemcel were being as compared to untreated children https://saddama578wyz2.salesmanwiki.com/user